INC-103

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameINC-103
Drug Alias NameStatin + ACE Inhibitor (Inncardio/Innovative Pharma)INC-103
ClassificationSmall molecules
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsHMG-CoA reductase inhibitors
TargetsAngiotensin-converting enzymeHMG-CoA reductase
Therapy Area/IndicationsHypercholesterolemiaHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsYes
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnovative Pharma Developments Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnovative Pharma Developments LtdLong-E International
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaHypertension

Other Information

ATC CodeN/A
Related LinksN/A